NEWS
- Beyond HER3-DXd: New Frontiers in HER3-Targeted Therapies for Lung Cancer
- siRNA Therapies for Alzheimer's Disease
- Dual-Payload ADCs: A Revolutionary Leap in Targeted Cancer Therapy
- HZ-PEG-HZ (1K) Successfully Completed The FDA DMF Filing
- BCMA/CD3 Bispecific Antibodies for Multiple Myeloma (MM)
- C-Met Therapies: Latest Advances & FDA Approvals
- Biological Therapies for Myasthenia Gravis: FDA-Approved and Emerging Treatments
- Polyethylene Glycol (PEG) Hydrogel Based 3D Bioprinting
- Meet Us at TIDES USA 2025, Booth #913
- Good News! mPEG-pALD (20K) Successfully Completed The FDA DMF Filing
